carbamates has been researched along with Hyperactivity, Motor in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Status epilepticus was induced by administration of KA either intraperitoneally (15 mg/kg) or by single intrahippocampal injection (1." | 1.40 | Retigabine calms seizure-induced behavior following status epilepticus. ( Ali, SS; Friedman, LK; Naseer, Z; Slomko, AM; Wongvravit, JP, 2014) |
| "Pretreatment with lamotrigine significantly attenuated AMPH/CDP-induced effects, but also reduced motility when tested in the presence of CDP-alone." | 1.35 | Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania. ( Nielsen, AN; Redrobe, JP, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slomko, AM | 1 |
| Naseer, Z | 1 |
| Ali, SS | 1 |
| Wongvravit, JP | 1 |
| Friedman, LK | 1 |
| Redrobe, JP | 1 |
| Nielsen, AN | 1 |
| Sagi, Y | 1 |
| Driguès, N | 1 |
| Youdim, MB | 1 |
| Tewfik, GI | 1 |
| Jain, VK | 1 |
| Harcup, M | 1 |
| Magowan, S | 1 |
1 trial available for carbamates and Hyperactivity, Motor
| Article | Year |
|---|---|
Effectiveness of various tranquilisers in the management of senile restlessness.
Topics: Aged; Carbamates; Chlorpromazine; Clinical Trials as Topic; Dementia; Female; Haloperidol; Humans; H | 1970 |
3 other studies available for carbamates and Hyperactivity, Motor
| Article | Year |
|---|---|
Retigabine calms seizure-induced behavior following status epilepticus.
Topics: Animals; Anticonvulsants; Anxiety; Behavior, Animal; Carbamates; Convulsants; Hippocampus; Hyperkine | 2014 |
Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
Topics: Amphetamine; Animals; Anticonvulsants; Antimanic Agents; Benzamides; Bipolar Disorder; Carbamates; C | 2009 |
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Carbamates; Cholinesterase Inhibitors; Dopamine; Hippocamp | 2005 |